Table 2.
Assessment of cytotoxicity in HCT-116 cells treated with calcium and gadolinium
| A: Annexin V–propidium iodide | B: Replating | ||||
|---|---|---|---|---|---|
| Group | % live | % Dead | % Apoptotic | Number of viable cells (×10−4) | |
| 5 hours | 5 hours | 18 hours | |||
| SMEM + dFBS | 96.2±1.2 | 2.9±1.0 | 0.7±0.2 | 3.2±0.9 | 3.9±1.3 |
| +1.5 mM calcium | 92.0±2.9 | 4.6±1.2 | 0.9±0.1 | 4.6+0.7 | 6.1±0.6 |
| +50 µM Gd3+ | 92.1±2.6 | 6.5±1.9 | 1.0±0.6 | 4.2±1.1 | 3.2±0.4* |
| +3.0 mM calcium | 91.8±1.6 | 6.6±1.1 | 1.1±0.9 | 4.4±1.1 | 6.1±0.7 |
| +50 µM Gd3+ | 91.6±2.9 | 7.0±2.8 | 0.8±0.3 | 4.9±0.6 | 2.5±0.7* |
Values shown are means and standard deviations based on duplicate experiments with three samples per data point for each condition in each experiment. Statistical significance of the data in the replating assay was assessed by ANOVA, followed by paired-group comparisons
p<0.05 (statistically significant decrease relative to controls)